Navigation Links
Drug Safety Experts Call for Increased Patient Involvement
Date:11/27/2007

World's first personalized electronic drug recall notice -- creating a new paradigm for the 21st century

WASHINGTON, Nov. 27 /PRNewswire-USNewswire/ -- National drug safety experts, including representatives from the Center for Medicine in the Public Interest (CMPI) and the Critical Path Institute (CPI), will gather at the National Press Club and call for an improved approach to providing consumers with real time and individualized information about the risks and benefits of drugs on the market.

Raising issues and looking at solutions available to people today, the panel will investigate the role of patient-centric drug safety; the role of patients in managing their medicines; new efforts to reduce the risk associated with prescription drugs; and new tools available to patients and physicians that empower them to have current, personalized information.

With nearly half of all Americans taking a prescription drug and one in six taking three or more, the opportunity for improved health and safer, more effective prescribing is significant.

In addressing this growing problem, drug safety experts will urge people to take a more active role in understanding the risks and benefits of their medicines through real time updates -- something that headline news or research cannot provide today. Journalists and representatives from patient advocacy groups will have the opportunity to have dialogue with the experts on critical and timely issues.

First direct-to-patient medication recall a major milestone in patient safety

In a world-first for patient safety, iGuard.org -- a new, free medication safety information service--recently sent the first personalized electronic nationwide recall alert to patients who take gabapentin. The recall, voluntarily initiated by Ranbaxy Laboratories, affects more than 73 million tablets worldwide. More than 400 iGuard registrants take gabapentin and received the alerts.

"We are really proud to be part of this first patient-centric medication recall," said Dr. Hugo Stephenson, founder and president of iGuard. "Based on the overwhelmingly positive reaction we've had from patients and doctors, it's about time we started thinking about who needs this information the most.... patients!"

Mrs. J. Rogers, a recent registrant with iGuard, said, "I never would have heard about the [gabapentin] recall had it not come to me directly. I'm surprised and shocked that such a system wasn't in existence already."

Stephenson said, "For years we have taken for granted that we'll get personal recall notices for the cars we buy. Now the same opportunity is finally available for people that take medications."

iGuard provides patients with a simple way to check interactions between their medications and receive personalized alerts and recall notices as they occur. In its first month of operation, and still in its "beta" stage, iGuard has registered almost 7,000 users and is averaging between 250 and 500 new registrations per day.

Despite recent attempts to communicate drug safety questions earlier, agencies such as the FDA and manufacturers have been hampered in their ability to reach patients with safety communications. iGuard represents a simple way for patients to voluntarily register for alerts without compromising their privacy. iGuard receives information for its alerts from regulators such as the FDA, from manufacturers, and from major journals that it monitors for breaking research.

About CMPI

CMPI is a non-profit institution founded to promote advances in genomics and health information technology that make medicine more predictive, preventive and personalized. We do that through research, outreach and solutions focusing on how to use 21st century science to personalize medicine, improve wellbeing and extend life.

About iGuard

iGuard is the fastest and easiest way for patients to get information and safety updates on the drugs they are taking. This drug safety monitoring program facilitates bi-directional exchange of timely and relevant information, enabling patients to take an active role in managing their health. iGuard maintains an efficient communication channel where patients and health professionals can monitor, evaluate and share information about drug risks and benefits. Registration is free online at http://www.iguard.org

About The Critical Path Institute

Based in Tucson, Ariz., with offices in Rockville, Md., The Critical Path Institute (C-Path) was established in 2005 as an independent nonprofit research and education institute to serve as a "trusted third party" for collaborations among scientists from government, industry and academia. C-Path's vision is to help implement the FDA's Critical Path Initiative by developing faster, safer and smarter pathways to new medical products. For more information, visit http://www.C-Path.org.
Breakfast Briefing Specifics

Topic: Patient-Centered Drug Safety for the 21st Century

Date: Tuesday, December 4, 2007

Time: 8:00 am - 10:00 am

Location: National Press Club

529 14th St. NW, 13th Floor - Washington, DC 20045


'/>"/>
SOURCE iGuard
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. More proof needed of safety and quality of electronic personal health records
2. Back to School Means Backpack Safety
3. Seniors Need a Safety Plan in Face of Disasters
4. New Survey Shows Americans are Still Concerned About Food Safety, Yet Still Not Smart About What They Like to Eat
5. National Patient Safety Foundation Partners with Vocera Communications
6. PA Governors Occupational Safety and Health Conference Still Accepting Registrations
7. QI projects may -- or may not -- improve patient safety and outcomes
8. The National Center for Missing & Exploited Children, Wal-Mart, and Abbott Host Child Safety Events
9. Cutting Salt Wont Affect Foods Safety
10. Microsoft Helps Developers of Clinical User Interfaces Improve Efficiency, Patient Safety With Free Toolkit
11. The Risk Management and Patient Safety Institute Announces Annual Health Care Risk Conference Dates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2017)... ... ... An inventor from Salisbury, N.C., knows the difficulties involved with leech therapy. "I ... to keep leeches in place during therapy," she said. "That’s why I came up ... to keep a leech in place on the skin during therapy. It prevents the ...
(Date:7/26/2017)... ... July 26, 2017 , ... Written By: Ashley D. Beall, ... in drug therapy for patients living with relapsing and primary multiple sclerosis that ... cell targeted therapy that has been proven to significantly reduce signs of disease ...
(Date:7/26/2017)... ... July 26, 2017 , ... Evergreen Healthcare ... of their continued efforts to provide innovative offerings to their healthcare partners. These ... and build dynamic, high-performing teams to address healthcare IT’s biggest challenges. , “Adding ...
(Date:7/26/2017)... ... July 26, 2017 , ... It may be hard to ... accessible to people in the third world. Diseases that many developed countries consider rare ... who don't have access to vaccines. , On an upcoming segment of "Success Files", ...
(Date:7/26/2017)... ... July 26, 2017 , ... ... 2017 Process Validation and Process Validation Statistics Conferences in Bethesda, Maryland, 12 ... lifecycle challenges faced by process validation professionals and statisticians today. , “These ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... July 12, 2017  Eli Lilly and Company (NYSE: ... generic companies to resolve pending patent litigation in the U.S. ... regarding the Cialis ® (tadalafil) unit dose ... 26, 2020. As part of the agreement, Cialis exclusivity is ... 2018. "The unit dose patent for Cialis is ...
(Date:7/11/2017)... , July 11, 2017  Sysmex America, ... urinalysis diagnostic testing equipment as well as middleware ... a way to make quality assurance easier and ... "Sysmex is well known for the innovation that ... Quality Monitor elevates quality assurance processes to a ...
(Date:7/10/2017)... -- The Institute for In Vitro Sciences (IIVS), a ... a VITROCELL® inhalation exposure system thanks to a generous ... which is designed to replace animals in inhalation testing, ... airborne test materials in an environment that mimics the ... testing combustible tobacco products, as well as next generation ...
Breaking Medicine Technology: